亚齐思罗米在儿科的安全概况:药物监督不成比例性分析
Yanfei Ren1, Bin Wang2, Hua Yang2
1College of Pharmacy, Dali University, Dali City, Yunnan Province, China.
Expert opinion on drug safety
|December 16, 2024
概括
这项研究分析了使用阿齐思罗米的儿童的不良药物事件 (ADEs),发现了常见的皮肤问题和罕见的婴儿缩性皮质狭窄症 (IHPS) 病例. 结果支持通过警更安全的儿科阿齐思罗米辛使用.
科学领域:
- 儿科药理学 儿科药理学
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
背景情况:
- 阿齐思罗米在儿童中被广泛使用.
- 对于儿童群体的药物不良事件 (ADEs) 的真实数据对于安全性评估至关重要.
- 对于临床实践来说,了解阿齐思罗米在儿童中的ADE概况至关重要.
研究的目的:
- 识别和分析与儿科患者的阿齐思罗米辛相关的不良药物事件 (ADE) 信号.
- 根据真实世界的数据,为儿童使用阿齐思罗米的安全性评估提供信息.
- 调查特定的有趣的ADEs,包括心律失常和婴儿高增量胆固醇狭窄症 (IHPS).
主要方法:
- 从FDA的不良事件报告系统 (FAERS) 中提取了2004年至2024年初儿童 (0-17岁) 的阿兹罗米辛的ADE报告.
- 使用医学监管活动词典 (MedDRA) 分类的ADE.
- 对于信号检测,雇员报告几率比率 (ROR) 和比例报告比率 (PRR).
主要成果:
- 收集了2203份涉及儿童阿齐思罗米的ADE报告,涵盖24个器官系统.
- 皮肤和皮下组织疾病是最常见的副作用,儿童更容易受到影响.
- 观察到2013年后心律失常报告的轻微增加,并确定了10例婴儿高性胆道狭窄症 (IHPS),主要在婴儿中.
结论:
- 这项研究提供了对儿科患者中阿齐思罗米不良药事件概况的关键见解.
- 这些发现支持加强临床警和风险识别,以便在儿童中更安全地处方阿齐思罗米辛.
- 监测常见和罕见的ADEs对于确保小儿群体安全使用阿齐思罗米至关重要.
相关概念视频
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
80
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
80
Analysis of Population Pharmacokinetic Data
224
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
224
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
43
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
43
Nonlinear Pharmacokinetics: Overview
268
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
268


